Cullinan Oncology Announces First Patients Dosed with Drug Candidates from Cullinan Apollo and Cullinan Pearl Cullinan Oncology Announces First Patients Dosed with Drug Candidates from Cullinan Apollo and Cullinan Pearl Matt Burke2019-12-18T21:30:52-05:00December 18, 2019| Read More
Cullinan Oncology CSO and MPM Capital Executive Partner Patrick Baeuerle Wins 2019 Xconomy “X of the Year” Award Matt Burke2019-09-26T13:54:28-05:00September 26, 2019| Read More
